EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immune dysregulation in type 2 diabetes mellitus: Implications for tuberculosis, COVID-19, and HIV/AIDS

Uzair Abbas, Harendra Kumar, Niaz Hussain, Ishfaque Ahmed, Rabeel Nawaz Laghari, Misha Tanveer, Mohammad Hadif, Kashaf Fatima, Muhib Ullah Khalid, Khadija Anwar, Mahtab Khan

Infectious Medicine · 2025-12 · 4 (4) · 100211

DOI: 10.1016/j.imj.2025.100211 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Infectious Medicine, 2025-12. Verfasst von Uzair Abbas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Dow University of Health Sciences, Karachi 74200, Pakistan. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) is a complex and multifactorial disorder associated with elevated blood sugar levels, poor insulin sensitivity, and inadequate insulin production. It has a major impact on the immune system, making a person more susceptible to and influenced by a variety of infectious illnesses. This narrative review summarizes the relationship between chronic inflammation and high glucose levels in DM, on susceptibility and outcomes in endemic infectious diseases. We focused on impact of DM on disease progression, and treatment response in these infections. Literature was identified through searches of PubMed, Scopus, and Google Scholar, focusing on epidemiologic, clinical, and mechanistic studies. The evidences suggest that immune modulation in DM has profound inverse relations with the outcome of infectious diseases including tuberculosis, COVID-19, and HIV/AIDS. DM increases the risk of developing severe forms of infectious diseases due to downregulation of the immune system which is associated with glycemic control. There is a need to understand the relationship between DM and immunological control for developing methods to reduce these risks and improve outcomes for the affected population.

Schlagwörter

Stichwörter der Autor:innen

COVID-19Diabetes mellitusDysregulationHIV/AIDSImmune modulationTuberculosisVaccine

Autor:innen und Institutionen

  • Department of Physiology, Dow University of Health Sciences, Karachi 74200, Pakistan.
  • Dow International Medical College, Dow University of Health Sciences, Karachi 74200, Pakistan.
  • Bilawal Medical College, Liaquat University of Medical and Health Sciences, Jamshoro 76080, Pakistan.
  • Sindh Infectious Diseases Hospital and Research Center, Dow University of Health Sciences, Karachi 75100, Pakistan.
  • Department of Medicine, Indus Medical College Hospital, Tando Muhammad Khan 70220, Pakistan.

Zitieren

APA

Abbas, U., Kumar, H., Hussain, N., Ahmed, I., Laghari, R. N., Tanveer, M., Hadif, M., Fatima, K., Khalid, M. U., Anwar, K., & Khan, M. (2025). Immune dysregulation in type 2 diabetes mellitus: Implications for tuberculosis, COVID-19, and HIV/AIDS. Infectious Medicine, 4(4), 100211. https://doi.org/10.1016/j.imj.2025.100211

Vancouver

Abbas U, Kumar H, Hussain N, Ahmed I, Laghari RN, Tanveer M, et al. Immune dysregulation in type 2 diabetes mellitus: Implications for tuberculosis, COVID-19, and HIV/AIDS. Infectious Medicine. 2025;4(4):100211. doi:10.1016/j.imj.2025.100211

BibTeX
@article{Abbas2025,
  author = {Abbas, Uzair and Kumar, Harendra and Hussain, Niaz and Ahmed, Ishfaque and Laghari, Rabeel Nawaz and Tanveer, Misha and Hadif, Mohammad and Fatima, Kashaf and Khalid, Muhib Ullah and Anwar, Khadija and Khan, Mahtab},
  title = {Immune dysregulation in type 2 diabetes mellitus: Implications for tuberculosis, COVID-19, and HIV/AIDS},
  journal = {Infectious Medicine},
  year = {2025},
  volume = {4},
  number = {4},
  pages = {100211},
  doi = {10.1016/j.imj.2025.100211}
}
Kostenlos starten →